These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7676293)

  • 21. Update on recent developments for patients with newly diagnosed multiple myeloma.
    Palumbo A; Magarotto V; Gay F; Falco P; Bringhen S; Boccadoro M
    Ann N Y Acad Sci; 2008 Sep; 1138():19-21. PubMed ID: 18837878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bortezomib plus melphalan and prednisone for multiple myeloma.
    Tsubokura M; Kami M; Komatsu T
    N Engl J Med; 2008 Dec; 359(24):2613; author reply 2613-4. PubMed ID: 19090031
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment with VAD of a myelodysplastic syndrome occurring during the course of a smoldering multiple myeloma.
    Cortesão E; Espadana A; Laranjeiro P; Jara M; Orfão A
    Leuk Res; 2009 Jan; 33(1):195-7. PubMed ID: 18511113
    [No Abstract]   [Full Text] [Related]  

  • 24. Bisphosphonates may potentiate effects of thalidomide-dexamethasone combination in advanced multiple myeloma.
    Ural AU; Avcu F
    Am J Hematol; 2006 May; 81(5):385-6; author reply 386. PubMed ID: 16628715
    [No Abstract]   [Full Text] [Related]  

  • 25. Lenalidomide and thalidomide: an evolving paradigm for the management of multiple myeloma.
    Anderson KC; Prince HM
    Semin Hematol; 2005 Oct; 42(4 Suppl 4):S1-2. PubMed ID: 16344096
    [No Abstract]   [Full Text] [Related]  

  • 26. Bortezomib plus melphalan and prednisone for multiple myeloma.
    Avvisati G
    N Engl J Med; 2008 Dec; 359(24):2613; author reply 2613-4. PubMed ID: 19090032
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of multiple myeloma].
    Brouet JC
    Rev Prat; 1993 Feb; 43(3):321-5. PubMed ID: 8502963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fifth biannual report of the Cochrane Haematologic Malignancies Group--Focus on multiple myeloma.
    Naumann F; Weingart O; Kruse E; Schulz H; Bohlius J; Hülsewede H; Engert A;
    J Natl Cancer Inst; 2006 Aug; 98(16):E2. PubMed ID: 16912255
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of resistant forms of multiple myeloma using a combination of mitoxantrone, vincristine and prednisone (the NOP regimen)].
    Scudla V; Bacovský J; Faltýnek L; Papajík T; Indrák K
    Vnitr Lek; 1993 Aug; 39(8):761-8. PubMed ID: 8212624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma.
    Hequet O; Dumontet C; El Jaafari-Corbin A; Salles G; Espinouse D; Arnaud P; Thieblemont C; Bouafia F; Coiffier B
    Bone Marrow Transplant; 2002 Mar; 29(6):544. PubMed ID: 11960281
    [No Abstract]   [Full Text] [Related]  

  • 31. [Multiple myeloma--advances in disease biology and implications for therapy].
    Chou T
    Gan To Kagaku Ryoho; 2001 Sep; 28(9):1206-12. PubMed ID: 11579631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Meningitis caused by Listeria monocytogenes in the patient with multiple myeloma].
    Pokrovskaia OS; Mendeleeva LP; Gribanova EO; Ustinova EN; Kliasova GA; Sharikova OA; Galstian GM; Iatskov KV; Varlamova EIu; Kaplanskaia IB
    Ter Arkh; 2003; 75(7):76-8. PubMed ID: 12934487
    [No Abstract]   [Full Text] [Related]  

  • 33. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.
    Pitini V; Arrigo C; Aloi G; Micali C; La Gattuta G
    Bone Marrow Transplant; 2003 Jun; 31(11):1065; author reply 1067. PubMed ID: 12774062
    [No Abstract]   [Full Text] [Related]  

  • 34. Thalidomide and dexamethasone in patients with multiple myeloma not undergoing upfront autologous stem cell transplantation.
    Blade J
    Haematologica; 2005 Dec; 90(12):1589. PubMed ID: 16330426
    [No Abstract]   [Full Text] [Related]  

  • 35. Lenalidomide: a new therapy for multiple myeloma.
    Palumbo A; Miguel JS; Sonneveld P; Moreau P; Drach J; Morgan G; Einsele H
    Cancer Treat Rev; 2008 May; 34(3):283-91. PubMed ID: 18230411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eastern Cooperative Oncology Group E1A00: phase III randomized study of dexamethasone with or without thalidomide in patients with newly diagnosed multiple myeloma.
    Greipp PR
    Clin Adv Hematol Oncol; 2003 Mar; 1(3):188-9. PubMed ID: 16224404
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma: final analysis of a phase II trial.
    Glasmacher A; Goldschmidt H; Mezger J; Haferlach T; Schmidt-Wolf IG; Gieseler F;
    Haematologica; 2004 Mar; 89(3):371-3. PubMed ID: 15020285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thoracic complications of multiple myeloma.
    Srinivasulu T; Choudary BP; Rao JR; Ushasree C; Vidyasagar C
    Indian J Chest Dis Allied Sci; 1988; 30(1):56-60. PubMed ID: 3169874
    [No Abstract]   [Full Text] [Related]  

  • 39. Thalidomide plus oral melphalan for advanced multiple myeloma: a phase II study.
    Offidani M; Marconi M; Corvatta L; Olivieri A; Catarini M; Leoni P
    Haematologica; 2003 Dec; 88(12):1432-3. PubMed ID: 14688003
    [No Abstract]   [Full Text] [Related]  

  • 40. Bortezomib data show improved survival in patients with relapsed multiple myeloma.
    Oncology (Williston Park); 2004 Aug; 18(9):1199, 1201. PubMed ID: 15471202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.